Publications

SSRN

Read Now

2019
Working Paper

Voting Trusts and Antitrust: Rethinking the Role of Shareholder Rights and Private Litigation in Public Regulation, 1880s to 1930s

By: Naomi R. Lamoreaux and Laura Phillips Sawyer

Scholars have long recognized that the states’ authority to charter corporations bolstered their antitrust powers in ways that were not available to the federal government. But they have also argued that the growth of large-scale enterprises operating in national and... View Details

Keywords: Voting Trusts; Antitrust; Business and Shareholder Relations; Lawsuits and Litigation; History; United States

Read Now

May 2011
Article

Race at the Top: How Companies Shape the Inclusion of African Americans on Their Boards in Response to Institutional Pressures

By: Clayton S. Rose and William T. Bielby

Drawing on institutionalist theory, we conceptualize the racial composition of the boards of directors of large American companies as shaped in response to social and political norms. We use new longitudinal and cross-sectional data to test hypotheses about factors... View Details

Keywords: Leadership; Governing and Advisory Boards; Race; Mathematical Methods; Government and Politics; Public Ownership; United States

Find at Harvard

September 2015
Case

GovDelivery

By: Mitchell Weiss

Is government the biggest, worst customer in the world? And is that a reason for venture investors to back companies that sell to government or to stay away? It had been seven years since Scott Burns joined his friend Zach Stabenow to get a company called GovDocs off... View Details

Keywords: GovDelivery; Public Entrepreneurship; B2G; Business-to-Government; Scott Burns; Entrepreneurship; Government Administration; Venture Capital; Public Administration Industry; Public Administration Industry; Public Administration Industry; Minnesota; United States

August 2024 (Revised February 2025)
Case

Novo Nordisk Foundation

By: Debora L. Spar and Julia M. Comeau

In 2024, Novo Nordisk A/S was one of the most profitable firms in the world, thanks largely to just two GLP-1-based drugs, Ozempic and Wegovy. Unusually, this incredibly profitable firm was controlled not by individual private shareholders, but by a non-profit... View Details

Keywords: Pharmaceutical Companies; Diabetes; Obesity; Foundation; Non-profit Management; Profit; Corporate Governance; Business or Company Management; Corporate Social Responsibility and Impact; Expansion; Philanthropy and Charitable Giving; Nonprofit Organizations; Pharmaceutical Industry; Denmark; Europe

July–August 2021
Article

SPACs: What You Need to Know

By: Max Bazerman and Paresh Patel

Special purpose acquisition companies, or SPACs, have been around in various forms for decades, but during the past two years they’ve taken off in the United States. In 2019, 59 were created, with $13 billion invested; in 2020, 247 were created, with $80 billion... View Details

Keywords: Special Purpose Acquisition Companies; SPACs; Mergers and Acquisitions; Going Public; Investment

Find at Harvard

Web

Serving the Public Interest Through Competition: British Railroads - Railroads and the Transformation of Capitalism | Harvard Business School

Railroads Finance Management Business Analysts Mass Distribution Mergers & Syndicates Research Links Serving the Public Interest Through Competition: British Railroads Through comparative analysis of railroads in the United States and... View Details

Fast Answer

Buying a Small Business Pt3: Screening brokers /small companies (For HBS Alumni)

public companies by industry, geography, Keywords, etc. America City Business Journal – provides local business news and information from more than forty cities across the United States. Open... View Details

04 Sep 2014
News

Our focus was to get drug companies to invest money in ALS

prize to identify a treatment that leads to a 25 percent extension in survival rates. “After eight years, in which we have raised over $10 million,” says Kremer, who lives in his native Israel and communicates via Skype and adaptive technologies, “most of the big drug... View Details

June 2023
Case

Block: Creating an Ecosystem of Ecosystems

By: Lauren Cohen, Richard Ryffel, Grace Headinger and Ruoshi Qi

At Investor Day 2022, Block announced a new vision for its businesses: creating an ecosystem of ecosystems. Outside the norm for many public growth companies, Block had recently acquired a variety of new business streams in the creator economy and Bitcoin despite a... View Details

July 2003 (Revised February 2004)
Background Note

M&A Legal Context: Standards Related to the Sale or Purchase of a Company

By: Carliss Y. Baldwin, Constance E. Bagley and James Quinn

Introduces students to the legal standards affecting officers and directors when selling or purchasing a company. Provides a practical understanding of the Revlon Standard, the Securities and Exchange Act of 1934, Rule 10b-5, and the legal criteria for a cause of... View Details

Keywords: Laws and Statutes; Law Enforcement; Government Legislation; Acquisition; Business Exit or Shutdown; Corporate Governance; Going Public; Courts and Trials

2017
Working Paper

The Benefits of Selective Disclosure: Evidence from Private Firms

By: Joan Farre-Mensa

Private firms’ ability to communicate confidentially with selected investors implies that valuation disagreements between firms and investors are larger at public firms than at private ones. Consistent with the notion that misvaluation concerns lead public firms to... View Details

Keywords: Finance; Equity; Private Companies; Corporate Cash; Precautionary Motives; Share Issuance; IPOs; Selective Disclosure; Private Ownership; Cash; Market Timing; Corporate Finance; Public Ownership; Corporate Disclosure; United States

SSRN

January 2014 (Revised June 2014)
Case

23andMe: Genetic Testing for Consumers (A)

By: John A. Quelch and Margaret L. Rodriguez

On November 22, 2013, the direct-to-consumer genetic testing provider, 23andMe, received a letter from the U.S. Food and Drug Administration (FDA) ordering the company to halt the sale and promotion of its genetic testing kit. The FDA stated that the product was... View Details

Keywords: Public Health; Genome Testing; Health Care; Ancestry; 23andMe; Marketing; Product Launch; Health; Health Care and Treatment; Health Testing and Trials; Genetics; Strategy; Health Industry; United States

2015
Book

MOVE: Putting America's Infrastructure Back in the Lead

By: Rosabeth M. Kanter

Americans are stuck. We live with travel delays on congested roads; shipping delays on clogged railways; and delays on repairs, project approvals, and funding due to gridlocked leadership. These delays affect us all, whether you are a daily commuter, a frequent flyer,... View Details